https://www.selleckchem.com/pr....oducts/sitravatinib-
No difference in PFS (median 4.9 vs 9.8ms, p=0.58) and OS (not reached vs 15.3ms, p=0.47) is found overall among younger and older patients respectively. The median follow-up was 72months (range, 11-288months). No genetic abnormalities were found. Young EOC patients are most often diagnosed at an early FIGO stage with LG serous or mucinous histology. Tumors are significantly more resistant to platinum-based chemotherapy in younger patients. Young EOC patients are most often diagnosed at an early FIGO stage with LG serous or
Like
Comment
Share
